The Company’s goodwill and intangible asset relate to the purchase of Rahko Limited (“Rahko”) in 2021, which was accounted for as a business combination.

Goodwill

Goodwill and the effect of foreign currency translation is as follows:


	Three Months Ended March 31, 2026
Goodwill balance as of January 1, 2026	$	14,327
Effect of foreign currency translation		(255	)
Goodwill balance as of March 31, 2026	$	14,072

Intangible Asset

The Company’s intangible asset is comprised solely of developed technology and is being amortized using the straight-line method which reflects the pattern in which the economic benefits of the asset are consumed, over its estimated useful life of five years.

The following tables present the intangible asset, current and future amortization, and the effect of foreign currency translation:


	Three Months Ended March 31, 2026
Intangible asset balance as of January 1, 2026	$	1,749
Effect of foreign currency translation		(31	)
Intangible asset balance as of March 31, 2026		1,718
Accumulated amortization		(1,558	)
Intangible asset, net	$	160

Future amortization:
2026		160
Total future amortization	$	160

Odyssey Therapeutics, Inc. 10-Q